A Randomized, Double-Blind, Active Comparator, Non-Inferiority Study of Subcutaneously Administered Neugranin (Recombinant Human Albumin-Human Granulocyte Colony Stimulating Factor) or Pegfilgrastim in Subjects with Breast Cancer Receiving Myelosuppressive Chemotherapy (Doxorubicin/Docetaxel) - NA
100 项与 Teva Pharmaceutical Works Pvt Ltd. Co. 相关的临床结果
0 项与 Teva Pharmaceutical Works Pvt Ltd. Co. 相关的专利(医药)
100 项与 Teva Pharmaceutical Works Pvt Ltd. Co. 相关的药物交易
100 项与 Teva Pharmaceutical Works Pvt Ltd. Co. 相关的转化医学